Reduction of urinary connective tissue growth factor by Losartan in type 1 patients with diabetic nephropathy

This publication has 27 references indexed in Scilit:

• Angiotensin II Increases Connective Tissue Growth Factor in the Kidney
  The American Journal of Pathology, 2003
• Connective Tissue Growth Factor Is a Mediator of Angiotensin II–Induced Fibrosis
  Circulation, 2003
• Urinary CCN2 (CTGF) as a possible predictor of diabetic nephropathy: Preliminary report
  Kidney International, 2003
• Long-Term Renoprotective Effects of Losartan in Diabetic Nephropathy
  Diabetes Care, 2003
• Urinary Transforming Growth Factor-β Excretion in Patients With Hypertension, Type 2 Diabetes, and Elevated Albumin Excretion Rate
  Diabetes Care, 2002
• Angiotensin II induces human TGF-β1 promoter activation: similarity to hyperglycaemia
  Diabetologia, 2002
• Effects of endothelin or angiotensin II receptor blockade on diabetes in the transgenic (mRen-2)27 rat
  Kidney International, 2000
• Expression of connective tissue growth factor in human renal fibrosis
  Kidney International, 1998
• The role of angiotensin II in diabetic nephropathy: Emphasis on nonhemodynamic mechanisms
  American Journal of Kidney Diseases, 1997
• A Simple Method for the Determination of Glomerular Filtration Rate
  Scandinavian Journal of Clinical and Laboratory Investigation, 1972